HUAKANG BIOMED(08622): Wang Yachun appointed as chairman of the remuneration committee.
Huakang Biomedical (08622) Announcement: Effective from July 8, 2025, the following changes will take effect: (1)...
HUAKANG BIOMED (08622) announced that, effective from July 8, 2025, the following changes will take effect: (1) Dr. Zheng Fading has resigned as an independent non-executive director of the company and will no longer serve as the chairman of the company's audit committee and remuneration committee; (2) Ms. Wang Yachun has been appointed as the chairman of the company's remuneration committee; and (3) Mr. Xu Yongde has been appointed as the chairman of the company's audit committee.
Related Articles

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


